Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: A retrospective single-center analysis

Annals of the New York Academy of Sciences

Volumn 941, Issue , 2001, Pages 217-219

  Wollina, U ^a,b   Liebold, K ^a   Kaatz, M ^a   Looks, A ^a   Stuhlert, A ^a   Lange, D ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Cutaneous T cell lymphoma; Extracorporeal photochemotherapy; Prospective controlled trial

Indexed keywords

ALPHA INTERFERON; METHOXSALEN;

ADULT; AGED; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PHOTOCHEMOTHERAPY; SKIN LYMPHOMA; SURVIVAL TIME; T CELL LYMPHOMA;

EID: 0034803562     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03728.x     Document Type: Conference Paper

References (7)

1. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy
2. Photopheresis for the treatment of cutaneous T cell-lymphoma
3. Extracorporeal photopheresis and interferon-α in advanced T-cell lymphoma
4. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a single institution
5. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy
6. Classification and staging
7. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas